Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APITA: Prednisone for Asthma Control Assessment
NCT00597064Phase 4Unknown
- Sponsor
- Federal University of São Paulo
- Start
- Jul 2006
- Primary completion
- Mar 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of prednisone in asthma, sponsored by Federal University of São Paulo. Primary endpoints: Asthma control status at 30 days and Forced Expiratory Volume in 1 second at 30 days. Status: unknown.
02
Drugs
prednisone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00597064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00597064.